Article: Mergers and acquisitions
A pandemic-proof industry? Pharma & Biotech thrive in a COVID world
Technology in healthcare can only go in one direction.
Ansarada Education
100 results found
FiltersArticle: Mergers and acquisitions
2021, wrapped
The best of a year of ups and downs.
Article: Due diligence and dealmaking
Four key M&A dealmaking trends to watch in 2023
We interviewed twelve leading M&A dealmakers across regions and industries to get their predictions and trends to watch for the year ahead.
Article: Due diligence and dealmaking
Are we on the brink of a global insolvency tsunami?
A wave of insolvencies is imminent, according to expert restructuring firm – so how can Directors worldwide turn the impacts of COVID into long-lasting, positive change? Virgin Australia, Travelex and Europoles demonstrate how it’s done.
Article: Industry news and trends
2021 has brought with it a new lens of focus for boards
The chaos of 2020 has forced boards and companies to use survival skills they never knew they had.
Article: Due diligence and dealmaking
Are we on the brink of a global insolvency tsunami?
A wave of insolvencies is imminent, according to expert restructuring firm – so how can Directors worldwide turn the impacts of COVID into long-lasting, positive change? Virgin Australia, Travelex and Europoles demonstrate how it’s done.
Article: Due diligence and dealmaking
Four key M&A dealmaking trends to watch in 2023
We interviewed twelve leading M&A dealmakers across regions and industries to get their predictions and trends to watch for the year ahead.
Article: Mergers and acquisitions
2021, wrapped
The best of a year of ups and downs.
Article: Industry news and trends
2021 has brought with it a new lens of focus for boards
The chaos of 2020 has forced boards and companies to use survival skills they never knew they had.
Article: Mergers and acquisitions
A pandemic-proof industry? Pharma & Biotech thrive in a COVID world
Technology in healthcare can only go in one direction.
